Clinical Trial Update: The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial update on escitalopram for depression in multiple sclerosis has been terminated, with no further efficacy or safety results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Multiple Sclerosis

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Depression, Multiple Sclerosis | Phase 4 | Status: TERMINATED